Houlihan Lokey Advises Charme Capital Partners

Houlihan Lokey is pleased to announce that Charme Capital Partners (Charme) has acquired Prism Healthcare Ltd. from European private equity firm Limerston Capital (Limerston). Limerston has retained a material minority shareholding and will remain invested in Prism Healthcare to support the group’s continued growth. The transaction was signed on 18 February 2022 and closed on 28 February 2022. Houlihan Lokey served as the buyside financial advisor on this transaction.

Established in 1984, Prism Healthcare employs over 650 people and operates from across nine UK locations, with a network of international distributors working across UK, European, and global markets. The group’s customers include both public authorities and private providers, helping healthcare professionals provide excellent care, promote learning, aid movement or recovery, and support independence. With a nationwide team of engineers and assessors, Prism Healthcare provides rapid development, delivery, installation, and servicing of equipment, which bring vital improvements to the quality of life of its end users.

Charme Capital Partners is based in London, Milan, and Madrid and is the manager of the Charme funds. The firm was founded in 2003 and is backed by a unique combination of institutional LPs and prominent global industrialists. Since inception, the Charme funds have raised over €1.8 billion and invested with a pan-European approach in companies with strong growth and internationalisation prospects.

This transaction represents a key patient mobility transaction announced from Houlihan Lokey’s European Healthcare team, further demonstrating the firm’s strong competences, versatility, and knowledge into the extremely active medtech space.